|
 BioPharm
International is the #1 magazine devoted to the science, strategies
and business trends shaping the global landscape for biotherapeutics.
BioPharm's focus on applied technologies utilized in biopharmaceutical
development and its focus on the business forces driving the industry's
growth has attracted a BPA-qualified, global audience of 29,200.
 BioProcess
International provides the biotechnology industry with monthly,
peer-reviewed information necessary to successfully drive products through
the biopharmaceutical, biovaccine and biodiagnostic development and
manufacture process. BPI's circulation consists of 30,000 mid-to-upper
managers working in all phases of the biotherapeutic development and
manufacturing process in the United States, Europe and Canada.
 European
Biotechnology Science & Industry News
The 15,000 circulated copies are directed at the decision-makers in
science and industry of the unified Europe. With the European Biotechnology
News magazine you can address a competent and specialized readership
in all 25 EU-countries, in Switzerland and Norway, predominantly in
the major biotech clusters, in renowned European research institutions,
as well as the current members of 20 scientific and corporate associations
and readers in the biotechnology and Life Sciences industry sector.
Topical industry news, background information on the current political
issues from Brussels, country specials as well as scientific and technical
highlights provide an attractive source of information.
The Williamsburg BioProcessing
Foundation (WilBio) was established in 1994 to advance the development
of safe and effective biological products by providing venues for the
exchange of bioprocess technology. In 2002, WilBio launched the BioProcessing
Journal? to enhance the exchange of bioprocess technology. Now in our
11th year, we have grown from six to 13 conference and from one to three
publications.
|
